Graf Akcie AVDL (Avadel Pharmaceuticals plc). Diskuze k akciím AVDL. Aktuální informace AVDL.

Základní informace o společnosti Avadel Pharmaceuticals plc (Akcie AVDL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 582.39M
Hodnota podniku (EV) N/A
Tržby 0.00
EBITDA N/A
Zisk -56.01
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 39.71
EV/EBITDA N/A
EV/EBIT 45.67
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book 3.68
Účetní hodnota na akcii 2.71
Hotovost na akcii 3.70
FCF vůči ceně -10.56 %
Počet zaměstnanců 2,020
Tržba na zaměstnance 0.00
Profit margin 31.47 %
Operating margin N/A %
Gross margin 74.29 %
EBIT margin N/A %
EBITDA margin -43.02 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -167.35 %
EPS - Očekávaný růst příští rok 90.00 %
Return on assets -18.44 %
Return on equity -38.05 %
ROIC 3.42 %
ROCE -22.47 %
Dluhy/Equity 0.92
Čistý dluh/EBITDA 8.98
Current ratio 14.17
Quick Ratio 14.17
Volatilita 6.06
Beta 0.86
RSI 59.64
Cílová cena analytiků 18
Známka akcie (dle analytiků) 1.00
Insider ownership 1.07 %
Institutional ownership 57.78 %
Počet akcií 58.596M
Procento shortovaných akcií 0.00 %
Short ratio 13.35 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2017
Země Ireland

Finanční výsledky akcie AVDL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$59.215$103.269$173.245$150.246$173.009$14.975
Cost Of Goods Sold$12.125$17.516$16.301$13.248$11.41$3.383
Gross Profit$47.09$85.753$156.944$136.998$161.599$11.592
Research And Development Expenses$32.917$39.329$33.418$34.611$25.608$17.298
SG&A Expenses$30.183$100.359$58.86$44.179$21.712$15.698
Other Operating Income Or Expenses$-0.845$-43.356$31.04$-49.285$-30.957$-60.504
Operating Expenses$83.327$208.195$83.74$155.211$102.251$108.632
Operating Income$-24.112$-104.926$89.505$-4.965$70.758$-93.657
Total Non-Operating Income/Expense$-14.47$-8.271$3.155$-4.753$6.947$3.526
Pre-Tax Income$-38.582$-113.197$92.66$-9.718$77.705$-90.131
Income Taxes$-5.356$-17.893$24.389$31.558$35.907$-0.644
Income After Taxes$-33.226$-95.304$68.271$-41.276$41.798$-89.487
Other Income------
Income From Continuous Operations$-33.226$-95.304$68.271$-41.276$41.798$-89.487
Income From Discontinued Operations-----$4.018
Net Income$-33.226$-95.304$68.271$-41.276$41.798$-85.469
EBITDA$-21.585$-94.673$95.12$9.524$83.89$-79.516
EBIT$-24.112$-104.926$89.505$-4.965$70.758$-93.657
Basic Shares Outstanding373740414136
Shares Outstanding373742414436
Basic EPS$-0.89$-2.55$1.69$-1.00$1.03$-2.36
EPS - Earnings Per Share$-0.89$-2.55$1.63$-1.00$0.96$-2.36
# 2020 2019 2018 2017 2016 2015
Current Ratio2.28943.25281.43262.90263.67751.5855
Long-term Debt / Capital1.31570.97650.00180.01280.00980.0488
Debt/Equity Ratio-4.167541.66910.00310.01940.01620.1493
Gross Margin79.523883.038590.590891.182593.40577.409
Operating Margin-40.7194-101.604651.6638-3.304640.8985-625.4224
EBIT Margin-40.7194-101.604651.6638-3.304640.8985-625.4224
EBITDA Margin-36.4519-91.676154.90496.338948.4888-530.9917
Pre-Tax Profit Margin-65.1558-109.613753.485-6.468144.9139-601.8764
Net Profit Margin-56.1108-92.287139.4072-27.472324.1594-570.7446
Asset Turnover0.3910.54270.6840.6120.80440.086
Inventory Turnover Ratio3.39643.67212.64764.06633.11240.5027
Receiveable Turnover7.15079.114711.71768.422323.10798.919
Days Sales In Receivables51.043940.045431.149743.337215.795540.9239
ROE - Return On Equity113.7915-3428.20379.7745-98.11560.4594-359.4578
Return On Tangible Equity68.503549.6194-270.9166-5570.302120.0471407.0367
ROA - Return On Assets-21.9406-50.080926.9551-16.814319.4336-51.3688
ROI - Return On Investment-35.9251-80.415879.6293-96.855659.8671-341.9188
Book Value Per Share-0.77820.07452.17511.01691.67630.6194
Operating Cash Flow Per Share1.1914-2.615-0.0593-1.47432.22570.5192
Free Cash Flow Per Share1.1996-2.6057-0.0443-1.4661.87030.8381